Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...

The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

Gilead Sciences, the maker of a twice-a-year anti-HIV injection, has approached South Africa’s medicine regulator to discuss ...

The Executive Director of UNAIDS Winnie Byanyima is calling for accelerated global solidarity to strengthen Madagascar's ...

Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...

In a groundbreaking development for HIV prevention, the efficacy and safety of a six-monthly injection containing the antiretroviral drug lenacapavir have been confirmed through two pivotal studies.

Given recent approvals and a promising pipeline, new biomedical HIV prevention tools for women have the potential to ...

Clarence Peeples is part of a small club in the HIV community. He is using his experiences to help fight the virus among ...

DEPUTY Minister for Livestock and Fisheries, Mr Alexander Mnyeti, has urged citizens to report any information regarding ...

In recent years the option to purchase medications from India has gained significant popularity offering a reliable and affordable solution for people worldwide India has emerged as a trusted source f ...